Niels Abildgaard

  • Clinical professor, Chief Physician, DMSc, Head of research Unit, KI, Haematology
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Conference abstract in journal
2019

A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group

Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F. H., Abildgaard, N., Nahi, H., Niels Frost, A., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Hveding Blimark, C., Linder, O., Tsykunova, G., Waage, A., Hansson, M. & Gulbrandsen, N., 13. Nov 2019, In : Blood. 134, Supplement 1, 601.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access

Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma: A randomized phase 2 trial by the nordic myeloma study group

Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F. H., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U., Axelsson, P., Stromberg, O., Blimark, C., Linder, O., Tsykunova, G., Waage, A., Hansson, M. & Guldbrandsen, N., Jun 2019, In : HemaSphere. 3, p. 737-738 S1602.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access

ESTUDIO POST-AUTORIZACIÓN EUROPEO DE SEGURIDAD DE PACIENTES CON MIELOMA MÚLTIPLE REFRACTARIO O EN RECAÍDA TRATADOS CON POMALIDOMIDA EN PRÁCTICA HABITUAL

Translated title of the contribution: EUROPEAN PATIENT SAFETY POST-AUTHORIZATION STUDY WITH MULTIPLE REFRACTORY MYELOMA OR IN RELAPSE TREATED WITH POMALIDOMIDE IN HABITUAL PRACTICEPayer, R. A., Gamberi, B., Abildgaard, N., Vekemans, M. C., Kyriakou, C., Di Raimondo, F., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., 21. Oct 2019, In : Haematologica. 104, S3, p. 200 1 p., PO-017.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

European Post-Authorization Safety Study of Patients With Relapsed or Refractory Multiple Myeloma Treated With Pomalidomide in a Real-World Setting

Gamberi, B., Abildgaard, N., Vekemans, M-C., Ramirez Payer, A., Kyriakou, C., Di Raimondo, F., Kueenburg, E. ., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., Oct 2019, In : Clinical Lymphoma, Myeloma & Leukemia. 19, 10 Suppl., p. e256 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Health-related quality of life is maintained with ixazomib maintenance in posttransplant newly diagnosed multiple myeloma: the TOURMALINE-MM3 trial

Dimopoulos1, M., Goldschmidt, H., Maisnar, V., Spicka, I., Abildgaard, N., Rowlings, P., Rajkumar, S. V., Cain, L., Romanus, D., Suryanaryan, K., Odom, D., Gnanasakthy, A. & Schjesvold, F. H., Oct 2019, In : Clinical Lymphoma, Myeloma & Leukemia. 19, 10 Suppl., p. 290-291 SP-151.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Immune electron microscopy and mass spectrometry for calssification of amyloid deposits

Abildgaard, N., Rojek, A. M., Elisabeth Højsgaard Møller, H., Toftmann Hansen, C., Palstrøm, N. B., Rasmussen, L. M., Beck, H. C. & Marcussen, N., Jun 2019, In : HemaSphere. 3, Supplement 1, p. 272-273

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Krd Consolidation in Myeloma Patients with a Positive PET-CT after Standard First Line Treatment: A Phase II Study (CONPET)

Nordberg Nørgaard, J., Abildgaard, N., Lysén, A., Revheim, M-E., Connelly, J. P. & Schjesvold, F. H., 13. Nov 2019, In : Blood. 134, Supplement 1, 3172.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access

Pomalidomide-based treatment in relapsed refractory mulitiple myeloma: Analysis of baseline characteristics and safety profile of patients who died in the European post approval safety study: PS1418

Gamberi, B., Abildgaard, N., Ramirez Payer, A., Kyriakou, C., Schmidt Hieber, M., Di Raimondo, F., Kueenburg, E. ., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., Jun 2019, In : HemaSphere. 3, 652.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Prognostic value of expression quantitative trait loci in multiple myeloma prognosis

Macauda, A., Piredda, C., Buda, G., Gemignani, F., Pelosini, M., Reis, R. M., Sainz, J., Tomczak, W., Zawirska, D., Rymko, M., Razny, M., Dudzinski, M., Druzd-Sitek, A., Garcia-Sanz, R., Watek, M., Subocz, E., Martinez Lopez, J., Prejzner, W., Jamroziak, K., Ebbesen, L. H. & 11 others, Butrym, A., Dumontet, C., Abildgaard, N., Mazur, G., Suska, A., Varkonyi, J., Kruszewski, M., Vangsted, A. J., Markiewicz, M., Canzian, F. & Campa, D., Oct 2019, In : European Journal of Human Genetics. 27, Suppl. 2, p. 1761-1762 2 p., P18.44D.

Research output: Contribution to journalConference abstract in journalResearch

Quality of life Appraisal processes in patients with multiple myeloma

Dueholm, J. R., Sonsby, L., Danbjorg, D. B., Abildgaard, N. & Nielsen, L. K., Oct 2019, In : Quality of Life Research. 28, Suppl. 1, p. S86 1057.

Research output: Contribution to journalConference abstract in journalResearch

Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

Redder, L., Klausen, T. W., Vangsted, A. J., Gregersen, H., Andersen, N. F., Pedersen, R. S., Plesner, T., Frederiksen, M., Frølund, U. C., Helleberg, C., Kongsgaard Nielsen, L., Salomo, M., Gimsing, P., Frederiksen, H. & Abildgaard, N., 13. Nov 2019, In : Blood. 134, Supplement 1, 1849.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

2018

Assessment of bone turnover in multiple myeloma patients before and after treatment

Zadeh, M. Z., Raynor, W., Østergaard, B., Taghvaei, R., Acosta-Montenegro, O., Seraj, S. M., Saboury, B., Al-Zaghal, A., Yellanki, D., Ayubcha, C., Werner, T., Abildgaard, N., Zhuang, H., Høilund-Carlsen, P. F. & Alavi, A., 2018, In : Journal of Nuclear Medicine. 59, Suppl. 1, p. 1429 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Carfilzomib-Cyclophosphamide-Dexamethasone induction and salvage ASCT transplant-eligible multiple myeloma with firs trelapse after upfront ASCT

Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F. H., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Frølund, U., Axelsson, P., Stromberg, O., Blimark, C., Carlson, K., Waage, A., Hansson, M. & Gulbrandsen, N., 15. Jun 2018, In : EHA Learning Center. 2018, PF720.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment

Zadeh, M. Z., Raynor, W., Østergaard, B., Taghvaei, R., Acosta-Montenegro, O., Seraj, S. M., Saboury, B., Yellanki, D., Al-Zaghal, A., Ayubcha, C., Werner, T., Abildgaard, N., Zhuang, H., Høilund-Carlsen, P. F. & Alavi, A., 2018, In : Journal of Nuclear Medicine. 59, Suppl. 1, p. 1430 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Clarithromycin added to the VCD regimen causes reduced health-related quality of life in multiple myeloma patients

Kongsgaard Nielsen, L., Klausen, TW., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Andersen, C. L., Vangsted, A. J., Abildgaard, N. & Gregersen, H., Jun 2018, In : HemaSphere. 2, Suppl. 1, p. 659-660 PS1440.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access
File
62 Downloads (Pure)

COMPLETE RESPONSE AND INDUCTION TREATMENT DOES NOT AFFECT SURVIVAL IN MYELOMA PATIENTS RELAPSING WITHIN 18 MONTHS FOLLOWING UP-FRONT HDM-ASCT. A POPULATION-BASED STUDY FROM 1994 TO 2015

Vangsted, A. J., Clemmensen, S., Dimopoulos, K., Frølund, U., Helleberg, C., Andersen, N. F., Abildgaard, N., Gimsing, P., Gregersen, H. & Klausen, T. W., 16. Jun 2018, In : EHA Learning Center. 2018, PS1308.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Schmidt-Hieber, M., Abildgaard, N., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Froen, H. F., Izarra, A. I., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 15. Jun 2018, In : EHA Learning Center.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

Eshoj, H. R., Nielsen, L. K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Helleberg, C., Frolund, U. C., Axelsson, P., Stromberg, O., Blimark, C., Carlson, K., Waage, A., Remes, K., Peceliunas, V., Guldbrandsen, N., Hansson, M. & Gregersen, H., Oct 2018, In : Quality of Life Research. 27, 1, p. S137 2048.

Research output: Contribution to journalConference abstract in journalResearch

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 2113 Trial

Zweegman, S., Schjesvold, F. H., van der Holt, B., Levin, M-D., Stege, C. A. M., Waage, A., Leijs, M. B. L., Klein, S. K., Szatkowski, D. L., Axelsson, P., Do, T. H., Knut-Bojanovska, D., van der Spek, E., Svirskaite, A., Poddighe, P., Stevens-Kroef, M., Hansson, M., van de Donk, N. W. C. J., Haukas, E., Sonneveld, P. & 1 others, Abildgaard, N., 29. Nov 2018, In : Blood. 132, Suppl. 1

Research output: Contribution to journalConference abstract in journalResearch

Measuring bone marrow activity with FDG-PET in multiple myeloma, smoldering myeloma, and healthy subjects

Raynor, W., Zadeh, M. Z., Acosta-Montenegro, O., Khosravi, M., Al-Zaghal, A., Yellanki, D., Østergaard, B., Werner, T., Zhuang, H., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2018, In : Journal of Nuclear Medicine. 59, Suppl. 1, p. 1420 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

NEW POTENTIAL CANDIDATE GENES IN MANTLE CELL LYMPHOMA

Cédile, O., Hansen, M. C., Ebbesen, L. H., Nørgaard Bentzen, H. H., Thomassen, M., Kruse, T. A., Kavan, S., Møller, M. B., Kielsgaard Kristensen, T., Christensen, J. H., Abildgaard, N. & Nyvold, C. G., 14. Jun 2018, In : EHA Learning Center. 2018, PB2322.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Population-based use of intravenous bisphosphonates in patients newly diagnosed with symptomatic multiple myeloma in Denmark in 2005-2015: Impact of patient characteristics

Ehrenstein, V., Ording, A. G., Ulrichsen, S. P., Andersen, I. T., Seesaghur, A., Helleberg, C., Silkjaer, T., Hernandez, R., Niepel, D. & Abildgaard, N., 1. Oct 2018, In : Annals of Oncology. 29, Suppl. 8, p. viii365 1 p.

Research output: Contribution to journalConference abstract in journalResearch

Open Access

Quality of life in newly diagnosed and relapsed Danish multiple myeloma patients: A national longitudinal study of Danish myeloma study group

Kongsgaard Nielsen, L., Jarden, M. E., Andersen, C. L., Frederiksen, H., Gregersen, H., Klostergaard, A., Steffensen, M. S., Pedersen, P. T., Broch, B., Frederiksen, M., Jensen, B. A., Helleberg, C., Mylin, A. K. & Abildgaard, N., Jun 2018, In : HemaSphere. 2, S1, p. 294-295 PF687.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access
File
118 Downloads (Pure)

Reason for not completing quality of life questionnaires in multiple myeloma patients

Kongsgaard Nielsen, L., King, M., Frederiksen, H., Frederiksen, M. & Abildgaard, N., Oct 2018, In : Quality of Life Research. 27, Suppl. 1

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Reason for not completing quality of life questionnaires in multiple myeloma patients

Nielsen, L. K., King, M., Jarden, M., Lykkegaard, C., Frederiksen, H., Gregersen, H., Klostergaard, A., Steffensen, M. S., Pedersen, P. T., Broch, B., Frederiksen, M., Jensen, B. A., Helleberg, C., Mylin, A. K. & Abildgaard, N., Oct 2018, In : Quality of Life Research. 27, 1, p. S43-S44 208.2.

Research output: Contribution to journalConference abstract in journalResearch

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Abildgaard, N., Vekemans, M-C., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Kentos, A., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 2. Dec 2018, In : Blood. 132, Suppl.1, p. 3286 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Systemic bone modelling in multiple myeloma, smoldering myeloma, and healthy subjects: Global assessment with NaF-PET

Raynor, W., Zadeh, M. Z., Acosta-Montenegro, O., Al-Zaghal, A., Yellanki, D., Østergaard, B., Werner, T., Zhuang, H., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2018, In : Journal of Nuclear Medicine. 59, Suppl. 1, p. 24

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Systemic bone remodeling in multiple myeloma, smoldering myeloma, and healthy subjects: Global assessment with NaF-PET

Raynor, W., Zadeh, M. Z., Acosta-Montenegro, O., Al-Zaghal, A., Yellanki, D., Oestergaard, B., Werner, T., Zhuang, H., Abildgaard, N., Hoilund-Carlsen, P. F. & Alavi, A., 1. May 2018, In : Journal of Nuclear Medicine. 59, Suppl. 1, p. 24 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

2017

Comparison of global uptake of NaF-PET/CT in whole-body bone in multiple myeloma and healthy controls

Zadeh, M. Z., Østergaard, B., Raynor, W., Taghvaei, R., Acosta-Montenegro, O., Ayubcha, C., Khosravi, M., Constantinescu, C. M., Nielsen, A. L., Werner, T., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2017, In : Journal of Nuclear Medicine. 58, Suppl. 1, p. 768

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Correlation of Dual Time Point FDG-PET with Response to Chemotherapy in Multiple Myeloma

Taghvaei, R., Østergaard, B., Zadeh, M. Z., Raynor, W., Paydary, K., Acosta-Montenegro, O., Nielsen, A. L., Werner, T., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2017, In : Journal of Nuclear Medicine. 58, Suppl. 1, 188.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Effects of chemotherapy on brain glucose metabolism in patients with multiple myeloma

Pourhassan Shamchi, S., Østergaard, B., Khosravi, M., Taghvaei, R., Emamzadehfard, S., Raynor, W., Castro, S., Nielsen, A. L., Werner, T., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2017, In : Journal of Nuclear Medicine. 58, Suppl. 1, 1262.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy

Østergaard, B., Shamchi, S. P., Taghvaei, R., Zirakchian, M. Z., Raynor, W., Nielsen, A. L., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 1. Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., p. 483-484 EP-0127.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

FDG-PET/CT in multiple myeloma: dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy

Østergaard, B., Taghvaei, R., Nielsen, A. L., Zirakchian, M. Z., Raynor, W., Asmussen, J. T., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 1. Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., p. 483 1 p., WHO 2016 C.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Feasibility of using global FDG uptake in bone marrow to assess treatment of multiple myeloma

Acosta-Montenegro, O., Raynor, W., Østergaard, B., Zadeh, M. Z., Taghvaei, R., Constantinescu, C. M., Werner, T., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2017, In : Journal of Nuclear Medicine. 58, Suppl. 1, p. 189

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Stege, C. A. M., van der Holt, B., Mellqvist, U-H., Levin, M-D., Salomo, M., Abildgaard, N., Bos, G., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M., Leijs, M. B. & 11 others, Sinnige, H., Haukås, E., van der Hem, K., Durian, M. F., Mattijssen, V., Gimsing, P., Van De Donk, N. WCJ., Stevens-Kroef, M., Sonneveld, P., Waage, A. & Zweegman, S., 2017, In : Blood. 130, Suppl. 1, 3146.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Global quantification of NaF in the skeleton: assessing bone formation in multiple myeloma patients before and after treatment

Raynor, W., Acosta-Montenegro, O., Østergaard, B., Zadeh, M. Z., Ayubcha, C., Taghvaei, R., Khosravi, M., Constantinescu, C. M., Werner, T., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2017, In : Journal of Nuclear Medicine. 58, Suppl. 1, p. 1214

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Health-Related Quality of Life (HRQoL) Measurements in Multiple Myeloma Patients Obtained By EORTC QLQ-C30; A Critical Review of Interpreting HRQoL Data in Longitudinal Studies

Kongsgaard Nielsen, L., Jarden, M. E., Andersen, C. L., Frederiksen, H. & Abildgaard, N., 2017, In : Blood. 128, 22, 540.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Initial Results from the Randomized Phase II HOVON-126/Nmsg 21.13 Trial

Zweegman, S., van der Holt, B., Schjesvold, F. H., Levin, M-D., Stege, C. A. M., Waage, A., Leijs, M. B., Klein, S., Szatkowski, D. L., Broyl, A., Axelsson, P., Hieu Do, T., Knut-Bojanovska, D., van der Spek, E. V. D. S., Svirskaite, A. S., Cunha, S., Hansson, M., Sonneveld, P., Haukås, E. & Abildgaard, N., 2017, In : Blood. 130, Suppl 1, 433.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group

Østergaard, B., Zadeh, M., Raynor, W., Taghvaei, R., Nielsen, A. L., Holdgaard, P. C., Asmussen, J. T., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, Suppl. 2, p. 484 1 p., EP-0128.

Research output: Contribution to journalConference abstract in journalResearch

NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group

Østergaard, B., Zadeh, M., Raynor, W., Taghvaei, R., Nielsen, A. L., Asmussen, J. T., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., p. 484-485 EP-0128.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma: results of the HOVON87/NMSG18 study

Stege, C. A. M., Kongsgaard Nielsen, L., Witte, B., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Gruber, A., Coenen, J., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M. & 14 others, Leys, R., Sinnige, H., Haukås, E., van der Hem, K., Durian, M., Mattijssen, V., Mattijssen, V., Gimsing, P., van de Donk, N., Stevens-Kroef, M., Sonneveld, P., Waage, A., Zweegman, S. & Abildgaard, N., 2017, In : Haematologica. 102, S2, p. 190 1 p., S501.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Quantification of the total bone marrow activity with FDG-PET in multiple myeloma before and after treatment: comparison with a control group

Zadeh, M. Z., Østergaard, B., Raynor, W., Taghvaei, R., Acosta-Montenegro, O., Khosravi, M., Nielsen, A. L., Constantinescu, C. M., Werner, T., Abildgaard, N., Høilund-Carlsen, P. F. & Alavi, A., 2017, In : Journal of Nuclear Medicine. 58, Suppl. 1, p. 190 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Time to Improve Bortezomib and Lenalidomide Lines of Therapy

Guidez, S., Demarquette, H., Caillot, D., J. Jurczyszyn, A., Pegourie, B., Chretien, M. L., Lancesseur, C., Karlin, L., Joao, C., Richez, V., Garderet, L., Ikhlef, S., Royer, B., Hulin, C., Banos, A., Voog, E., Stoppa, A-M., Benboubker, L., Abildgaard, N., Le Du, K. & 7 others, Moreau, P., Facon, T., Zweegman, S., Macro, M., Gay, F. M., Terpos, E. & Leleu, X., 2017, In : Blood. 130, Suppl. 1, 1853.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

2016

18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones

Østergaard, B., Nielsen, A. L., Møller, H. E. H., Preiss, B. S., Asmussen, J. T., Mortensen, J. R., Plesner, T., Gerke, O., Alavi, A., Høilund-Carlsen, P. F. & Abildgaard, N., 2016, In : Blood. 128, 22, 3260.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma

Østergaard, B., Nielsen, A. L., Gerke, O., Mortensen, J. R., Asmussen, J. T., Plesner, T., Ormstrup, T., Holdgaard, P. C., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 1. Oct 2016, In : European Journal of Nuclear Medicine and Molecular Imaging. 43, 1 Suppl. 1, p. S438 1 p., EP559.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders: a Study of the International Myeloma Working Group

Hillengass, J., Monopoulos, L. A., Delorme, S., Koutoulidis, V., Hielscher, T., Engelhart, J., Drake, M. T., Rajkumar, V., Østergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Caers, J., Withofs, N., Dimopoulos1, M., Goldschmidt, H., Lentzsch, S., Durie, B. G. & 1 others, Terpos, E., 2016, In : Blood. 128, 22, 4468.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

2015

A systematic literature review and network meta-analysis of treatments for patients with transplant-ineligible newly diagnosed multiple myeloma

Katja, W., Doyen, C., Dimopoulos, M. A., Yee, A., Kropff, M., Lahuerta, J. J., Martin, A., Travers, K., Abildgaard, N., Jin, L., Van Droogenbroeck, J., Geraldes, C., Petrini, M., Voillat, L., Vilque, JP., Voog, E. & Facon, T., 11. Jun 2015, In : Haematologica. 100, S1, p. 250 1 p., P645.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Can overall survival be improved in elderly multiple myeloma patients?

Heeg, B., Liwing, J., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., Anttila, P., Remes, K., Abildgaard, N., Waage, A. & Nahi, H., 2015, In : Haematologica. 100, S1, p. 517 1 p., E1289.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Central Nervous System Involvement by Multiple Myeloma: A Multi-Institutional Retrospective Study of 172 Patients

Jurczyszyn, A., Gozzetti, A., Cerase, A., Hungria, V., Crusoe, E., Silva, A. L., Vij, R., Fiala, M. A., Caers, J., Rasche, L., Nooka, A. K., Lonial, S., Vesole, D. H., Philip, S., Gangatharan, S., Druzd-Sitek, A., Walewski, J., Corso, A., Cocito, F., Vekemans, M. C. M. & 32 others, Atilla, E., Beksac, M., Leleu, X., Davila, J., Badros, A., Niesvizky, R., Aneja, E., Abildgaard, N., Kastritis, E., Fantl, D., Schutz, N., Pika, T., Olszewska-Szopa, M., Butrym, A., Usnarska-Zubkiewicz, L., Grz ko, N., Usmani, S., Nahi, H., Chim, C. S., Shustik, C., Dry, K. M., Lentzsch, S., Widerska, A., Helbig, G., Guzicka-Kazimierczak, R., Lendvain, N., Waage, A., Andersen, K. T., Murakami, H., Zweegman, S., Skotnicki, A. B. & Castillo, J. J., 2015, In : Clinical Lymphoma, Myeloma & Leukemia. 15, S3, p. e128-e129

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Open Access